Free Trial

Camtek (CAMT) Competitors

Camtek logo
$65.78 +0.48 (+0.74%)
As of 05/20/2025 04:00 PM Eastern

CAMT vs. RVTY, AVTR, BIO.B, NVMI, VNT, ST, MIR, TXG, TRNS, and ALNT

Should you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Sensata Technologies (ST), Mirion Technologies (MIR), 10x Genomics (TXG), Transcat (TRNS), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry.

Camtek vs.

Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Camtek has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Revvity has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Camtek$450.86M6.65$118.51M$2.6125.20
Revvity$2.77B3.97$270.39M$2.3539.74

In the previous week, Camtek had 8 more articles in the media than Revvity. MarketBeat recorded 20 mentions for Camtek and 12 mentions for Revvity. Revvity's average media sentiment score of 1.26 beat Camtek's score of 0.51 indicating that Revvity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Camtek
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
7 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Camtek pays an annual dividend of $1.33 per share and has a dividend yield of 2.0%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Camtek pays out 51.0% of its earnings in the form of a dividend. Revvity pays out 11.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

41.9% of Camtek shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 79.4% of Camtek shares are owned by insiders. Comparatively, 0.7% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Camtek received 528 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.09% of users gave Camtek an outperform vote while only 63.64% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
CamtekOutperform Votes
563
71.09%
Underperform Votes
229
28.91%
RevvityOutperform Votes
35
63.64%
Underperform Votes
20
36.36%

Camtek has a net margin of 27.61% compared to Revvity's net margin of 9.81%. Camtek's return on equity of 24.99% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Camtek27.61% 24.99% 14.81%
Revvity 9.81%7.68%4.62%

Camtek currently has a consensus target price of $90.78, indicating a potential upside of 38.00%. Revvity has a consensus target price of $125.64, indicating a potential upside of 34.54%. Given Camtek's stronger consensus rating and higher probable upside, research analysts plainly believe Camtek is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Camtek
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
Revvity
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Camtek beats Revvity on 13 of the 20 factors compared between the two stocks.

Get Camtek News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAMT vs. The Competition

MetricCamtekOptical instruments & lenses IndustryComputer SectorNASDAQ Exchange
Market Cap$3.00B$14.18B$25.24B$8.48B
Dividend Yield2.25%1.56%2.89%4.11%
P/E Ratio27.1838.7945.0820.05
Price / Sales6.656.172,149.00116.47
Price / Cash39.5320.2234.7834.62
Price / Book5.436.606.794.61
Net Income$118.51M$324.03M$737.99M$248.19M
7 Day Performance-5.80%-0.94%0.55%2.97%
1 Month Performance12.21%17.65%16.30%16.58%
1 Year Performance-34.77%-2.65%52,512.20%8.16%

Camtek Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAMT
Camtek
4.2381 of 5 stars
$65.78
+0.7%
$90.78
+38.0%
-34.1%$3.00B$450.86M27.18400
RVTY
Revvity
4.12 of 5 stars
$98.64
+8.1%
$125.64
+27.4%
-16.6%$11.63B$2.77B44.6316,700Positive News
AVTR
Avantor
4.9214 of 5 stars
$12.98
+8.0%
$18.88
+45.4%
-46.0%$8.84B$6.69B12.4814,500Positive News
Gap Up
BIO.B
Bio-Rad Laboratories
N/A$234.41
flat
N/A-10.7%$6.57B$2.54B-3.608,200
NVMI
Nova
3.1335 of 5 stars
$195.64
+6.6%
$269.60
+37.8%
-7.2%$5.73B$672.40M34.081,180Gap Up
VNT
Vontier
3.4057 of 5 stars
$36.64
+5.1%
$43.67
+19.2%
-9.0%$5.42B$2.96B13.328,100Positive News
Analyst Forecast
Gap Up
ST
Sensata Technologies
4.9358 of 5 stars
$27.75
+8.6%
$33.58
+21.0%
-37.0%$4.06B$3.84B33.0420,800Positive News
Analyst Forecast
Gap Up
MIR
Mirion Technologies
0.9979 of 5 stars
$16.96
+3.5%
$18.75
+10.6%
+62.6%$3.93B$870.20M-89.262,870Positive News
Gap Up
TXG
10x Genomics
4.5421 of 5 stars
$9.49
+8.2%
$17.81
+87.6%
-63.4%$1.16B$624.66M-6.241,240Analyst Forecast
TRNS
Transcat
1.1754 of 5 stars
$82.39
+4.7%
$111.50
+35.3%
-24.0%$766.97M$272.20M44.54920News Coverage
Earnings Report
Analyst Upgrade
Gap Up
ALNT
Allient
2.6622 of 5 stars
$29.85
+3.8%
$31.00
+3.9%
+9.0%$505.33M$516.06M33.921,950Gap Up

Related Companies and Tools


This page (NASDAQ:CAMT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners